Innoviva (INVA) Receivables (2012 - 2026)
Innoviva (INVA) reported Receivables of $50.83 million for Q2 2026, up 142.9% from $20.93 million a year earlier and up 49.5% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Receivables (2012 - 2026) Analysis & Trends
At the end of FY2025, Innoviva posted Receivables of $34.97 million, up 71.5% from FY2024.
- Receivables has increased for three consecutive years, though with a four-year compound annual growth rate of -25.0% (FY2021 to FY2025).
- By year, Receivables came in at $20.39 million in FY2024 (+41.1%), $14.45 million in FY2023 (+53.7%), $9.4 million in FY2022 (-91.5%) and $110.71 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Receivables since Q4 2021.
- Year over year, Receivables has now increased in each of the last three quarters, with growth averaging 50.6% over the last seven quarters.
- The high point for year-over-year Receivables in five years was Q2 2026 (growth of 142.9%); the low point was Q4 2022 (a decline of 91.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $34.01 million (Q1 2026), $34.97 million (Q4 2025) and $30.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Innoviva | 1.54 Bn | -748.67 Mn | 90.62 Mn | 50.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.83 Mn |
| Mar 31, 2026 | 34.01 Mn |
| Dec 31, 2025 | 34.97 Mn |
| Sep 30, 2025 | 30.17 Mn |
| Jun 30, 2025 | 20.93 Mn |
| Mar 31, 2025 | 16.67 Mn |
| Dec 31, 2024 | 20.39 Mn |
| Sep 30, 2024 | 30.55 Mn |
| Jun 30, 2024 | 26.78 Mn |
| Mar 31, 2024 | 14.14 Mn |
| Dec 31, 2023 | 14.45 Mn |
| Sep 30, 2023 | 10.75 Mn |
| Jun 30, 2023 | 15.28 Mn |
| Mar 31, 2023 | 15.49 Mn |
| Dec 31, 2022 | 9.40 Mn |
| Sep 30, 2022 | 72.35 Mn |
| Dec 31, 2021 | 110.71 Mn |
| Dec 31, 2014 | 10.55 Mn |
| Sep 30, 2014 | 4.01 Mn |
| Jun 30, 2014 | 3.47 Mn |
API Access
Innoviva Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();